Background: Evidence for benefit of endovascular aneurysm repair (EVAR) over open surgical repair for de novo infrarenal abdominal aortic aneurysms (AAAs) in younger patients remains conflicting because of heterogeneous study populations and small sample sizes. The objective of this study was to compare perioperative and short-term outcomes for EVAR and open surgery in younger patients using a large national disease and procedure-specific data set.
Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs) has increasingly replaced open surgical repair as the standard of care for anatomically suitable candidates. 1, 2 By 2006, EVAR utilization had risen to >70% 3 and continued at this rate through 2010. 4 EVAR has been shown to have a significant perioperative mortality and morbidity advantage that decreases over time, 5, 6 especially among the elderly or those with significant comorbid conditions but even in acceptable-risk patients. However, this perioperative advantage may be less in lower risk populations, such as patients with fewer medical comorbidities or those of a younger age with longer life expectancies. 7 EVAR has been shown to be potentially less durable compared with open repair over time, requiring more reinterventions and with a small but persistent risk of aneurysm rupture. 6, 8 The declining effectiveness of EVAR over time may make open repair an acceptable alternative for younger patients if the perioperative morbidity and mortality risks in this population are The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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METHODS
This study of deidentified national registry data was approved by the Society for Vascular Surgery Patient Safety Organization Research Advisory Committee and our Institutional Review Board before data acquisition and analysis. This study was exempt from informed consent because of the deidentified nature of the data. We identified and included patients 65 years of age or younger undergoing AAA repair using the Vascular Quality Initiative (VQI) EVAR and open repair registries from 2003 to 2014. We sought to compare only patients with AAAs that were amenable to either open repair or EVAR. In an attempt to approximate these parameters, exclusion criteria included any pararenal EVAR chimney or fenestrated operations as well as any open repairs involving suprarenal clamping and pararenal or thoracoabdominal aneurysms. Repairs performed for isolated iliac aneurysm were also excluded. To preserve the comparability of the two groups, EVAR patients who were deemed medically unfit for open repair as designated on the intake form by the operative surgeon were also excluded. For patients with multiple recorded AAA repairs in the database, the earliest repair was used as the index procedure.
The primary comparison groups were EVAR and open repair. Although these two procedures were recorded in two distinct registries, the outcome measure variables were consistent across both data sets. The primary outcome measures were in-hospital mortality and morbidity rates. Primary morbidity measures were myocardial infarction, respiratory failure (defined in the VQI registry as prolonged intubation), need for new-onset hemodialysis, and acute stroke. Biomarkeronly elevations such as transient elevated troponin or creatinine elevation without clinical diagnosis of myocardial infarction or need for hemodialysis were not included as these may be subject to significant selection bias from differing baseline hospitalization courses of the two procedures. Secondary outcomes were reintervention rates over time and 1-year survival based on Social Security Death Index-linked death records present in the VQI data. Follow-up rates were limited to 1 year as institutional follow-up past 1 year is not required for participation in the VQI; those without follow-up were excluded from longitudinal analysis.
Propensity weighting was used to further balance and adjust for clinical and comorbid characteristics between the EVAR and open repair groups. The propensity for receiving EVAR vs open repair was fit using a logistic model and clinically relevant covariates. Covariates were included following the stepwise inclusion method described by Imbens and Rubin 9 or forced into the model if deemed clinically relevant (Supplementary Table, online only). The comparability of the two initial cohorts was confirmed by qualitatively examining the overlapping distributions of propensity scores (common support; Supplementary Fig 1, online only ). An inverse probability of treatment weight based on the propensity score was then calculated for each subject and applied to both cohorts; stabilized weights were used to correct for outliers. 10 Adequate balance between the weighted EVAR and open repair groups was confirmed using standardized differences. 9 The final adjusted analyses were conducted using these weighted cohorts. A supplemental analysis extended this study to those up to the age of 70 years.
Statistical analysis. Two-sample t-test, c 2 test, Fisher exact test, Wilcoxon rank sum test, and Kruskal-Wallis test were used for unadjusted comparisons between the two cohorts where appropriate. Normality was assessed qualitatively using histogram plots for continuous variables. Analysis of in-hospital and 1-year binary outcomes was performed using logistic regression; analysis of reintervention rates over time was done using negative binomial regression to account for multiple reinterventions per patient. All analyses were performed using Stata 13.1 (StataCorp LP, College Station, Tex) and R 3.1.0 (R Foundation for Statistical Computing, Vienna, Austria). (27%; n ¼ 713). The median age was 62 years (interquartile range [IQR], 59-64 years), and 13% were female (n ¼ 337). The median follow-up time was 401 days (IQR, 357-459 days). EVAR patients were significantly older and had higher rates of comorbidities, including diabetes, coronary heart disease, congestive heart failure, emphysema, and previous coronary bypass or intervention (Table I) After propensity weighting, the two weighted cohorts were found to be adequately balanced over the relevant covariates (Supplementary Fig 2, online only) . Analysis of the propensity-weighted cohorts continued to demonstrate a statistical difference in the rates of in-hospital mortality and morbidity, although the rates of mortality (open repair, 0.9%; EVAR, 0.2%) and myocardial infarction were extremely low at <1%. No significant difference was demonstrated in the risk of postoperative stroke between the two groups (Fig 1) . Propensityweighted survival (hazard ratio, 0.88; 95% confidence interval [CI], 0.56-1.38; P ¼ .6) and reintervention rates (incidence rate ratio, 1.35; 95% CI, 0.57-3.21; P ¼ .5) did not differ between the two methods of repair. An extension analysis of perioperative outcomes in those 70 years of age or younger showed similar results (Fig 2) .
RESULTS

DISCUSSION
Large nonrandomized contemporary studies of AAA repair have suffered from ascertainment bias due to the inherent incomparability of real-world open surgical and endovascular cohorts. This is often unavoidable because of the necessary tradeoff between granularity and sample size in large administrative databases. 6 Whereas EVAR has been employed for more than two decades, early endografts have shown a propensity toward device-related complications, such as material fatigue and migration, in extended follow-up. 13 The current generation of endografts have been in use only for the past decade; long-term durability of these devices remains unknown but has a clear dependence on adherence to the device instructions for use. 14 As such, young or fit patients who have equivalent morbidity and mortality outcomes with open or endovascular repair may warrant further long-term comparative study during which endograft failure and persistent risk of rupture may prove to be significant. Our study sought to examine perioperative results in younger patients. Although various cut points have been suggested for defining "younger" patients, the majority of previous studies have identified those #65 years of age as younger 12 ; in addition to this cut point, we extended this study in a subgroup analysis of those younger than 70 years. cohorts was low at <1%, under the practical threshold for determining high-risk operations. 15 repair are higher than in our study but are likely to be due to the inability to exclude complex aneurysms, such as those requiring suprarenal clamping. Rates of perioperative myocardial infarction were likewise statistically significant in favor of EVAR but <1% in both cohorts, and the rate of perioperative stroke was nonsignificant. Similar but much smaller studies in select populations of patients have also been carried out using registry data from the Vascular Study Group of New England 7 and the National Surgical Quality Improvement Program, 18 primarily in patients younger than 60 years.
Neither of these studies could demonstrate statistically significant mortality differences between the two cohorts, probably because of small sample size (169 in the Vascular Study Group of New England and 651 in the National Surgical Quality Improvement Program study). In contrast, the large sample size of our study allows more certainty in determining incidence of perioperative outcomes and true differences between the two groups. Open AAA repair did, however, have a significantly higher rate of respiratory failure and renal failure requiring hemodialysis that reflect clinically significant differences. This is not surprising, given that open repair requires a laparotomy and manipulation of the pararenal aorta. However, this should figure prominently into any surgeon's risk-benefit analysis, given the morbidity carried by respiratory failure and prolonged intubation. 19 The increased need for aorta-related reintervention after EVAR as opposed to open repair has been suggested on the basis of both randomized 16, 20 and large cohort data 6, 8 for both minor and major aorta-related reinterventions. In addition, the mortality benefit of EVAR over open repair has been shown to decrease over time, at least in the general population. At 1 year in our study, survival rates were almost identical between the cohorts; however, the difficulty of tracking true mortality and the large percentage of loss to follow-up in the VQI data make assessment of outcomes outside of the immediate perioperative period difficult. This suggests that further study is needed to define concrete benefits related to the use of EVAR in younger patients with longer life spans. Recent studies have suggested that patients with fewer anatomically favorable criteria for EVAR may be more likely to experience more long-term complications compared with those with favorable aneurysm anatomy, 14, 21 although solid evidence to support this conclusion remains limited and conflicting. 22 Studying younger patients within this "off-instructions for use" cohort with unfavorable aneurysm anatomy for EVAR may identify a population potentially benefiting from open repair.
Perioperative outcomes such as mortality may not be the only driver for decisions for the type of aneurysm repair in younger patients. Other factors, such as short-term quality of life and return to work, may figure significantly in these decisions. Further research is needed in this area and in this specific population, as this type of data is not available in many clinically focused studies such as ours.
Our study does have some limitations that must be considered in interpreting these results. The VQI is a voluntary registry, with the potential for bias arising from both the self-reported nature of the data and selection bias from the centers participating in the registry, as centers participating in the registry may have systematically different treatment algorithms, populations of patients, or disease characteristics than those not participating. Despite our best attempts to adjust for differences between the two cohorts using all of the available information, first by excluding complex aneurysms and then by using propensity methods, the absence of anatomic data or other unmeasured confounders may have an impact on the comparability of the two groups. Analysis of the data is also complicated by significant amounts of missing data for 1-year followup because of the voluntary submission nature of the database. The nature of the improvement of endovascular technology and techniques during the 10-year collection period must also be accounted for in interpreting the results of these studies. Finally, the 1-year follow-up period is a limited window into the durability of either open repair or EVAR and cannot reliably determine long-term aneurysm behavior. Further long-term study is necessary to determine the durability of these interventions in this population of younger patients.
CONCLUSIONS
Although EVAR has largely supplanted open AAA repair as the standard treatment modality of choice because of favorable morbidity and mortality profiles, the long-term durability of these devices remains unclear. Our study demonstrates that open repair carries similar perioperative mortality risks compared with EVAR in highly select populations, such as those of younger age, although with a concomitantly higher rate of respiratory complications. Further study is needed regarding the long-term mortality and aorta-related reintervention rates for both treatment paradigms to identify populations in which open AAA repair may provide a durable long-term alternative to EVAR. 
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